Tomorrow’s Challenges for Herpesvirus Management: Potential Applications of Valacyclovir
Open Access
- 15 October 2002
- journal article
- review article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 186 (s1) , S131-S137
- https://doi.org/10.1086/342960
Abstract
Controlled trials suggest that acyclovir/valacyclovir can provide significant clinical benefits when used for prophylaxis in the immunocompromised hoKeywords
This publication has 45 references indexed in Scilit:
- Clinical Manifestations and Treatment Considerations of Herpes Simplex Virus InfectionThe Journal of Infectious Diseases, 2002
- Challenges in Genital Herpes Simplex Virus ManagementThe Journal of Infectious Diseases, 2002
- Herpes simplex virus latency and nucleoside analoguesAntiviral Research, 1999
- Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipientsThe Lancet, 1997
- Recurrence and Resistance Patterns of Herpes Simplex Virus following Cessation of >=6 Years of Chronic Suppression with AcyclovirThe Journal of Infectious Diseases, 1994
- Laboratory studies of herpes simplex virus strains resistant to acyclovirReviews in Medical Virology, 1991
- Preemptive Therapy in Immunocompromised HostsNew England Journal of Medicine, 1991
- Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate.Proceedings of the National Academy of Sciences, 1989
- Vidarabine versus Acyclovir Therapy in Herpes Simplex EncephalitisNew England Journal of Medicine, 1986
- Adenine Arabinoside Therapy of Biopsy-Proved Herpes Simplex EncephalitisNew England Journal of Medicine, 1977